CDNA - Caredx Inc
IEX Last Trade
30.69
-0.220 -0.717%
Share volume: 1,470,396
Last Updated: Fri 30 Aug 2024 09:59:59 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$30.91
-0.22
-0.71%
View ratios
| Fiscal Date | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | 2024-06-30 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | |
| Report Date | 2022-11-03 | 2023-02-27 | 2023-05-10 | 2023-08-08 | 2023-11-08 | 2024-02-28 | 2024-05-09 | 2024-07-31 | |
| Assets | |||||||||
| Total Assets | 544.511 M | 542.991 M | 528.217 M | 514.820 M | 501.180 M | 466.826 M | 452.406 M | 466.777 M | |
| Current Assets | 388.157 M | 387.849 M | 371.428 M | 360.814 M | 345.166 M | 313.713 M | 303.095 M | 320.609 M | |
| Inventories | 18.086 M | 19.232 M | 18.018 M | 18.840 M | 17.978 M | 19.471 M | 20.130 M | 19.234 M | |
| Other Current Assets | 8.370 M | 9.216 M | 8.161 M | 7.676 M | 7.310 M | 7.763 M | 6.895 M | 6.343 M | |
| Short Term Investments | 8.370 M | 9.216 M | 8.161 M | 7.676 M | 7.310 M | 7.763 M | 6.895 M | 6.343 M | |
| Total Receivables | 70.425 M | 66.312 M | 59.310 M | 51.625 M | 51.694 M | 51.061 M | 60.149 M | 66.161 M | |
| Current Cash | 291.276 M | 293.089 M | 285.939 M | 282.673 M | 268.184 M | 235.418 M | 215.921 M | 228.871 M | |
| Total Non-current Assets | 156.354 M | 155.142 M | 156.789 M | 154.006 M | 156.014 M | 153.113 M | 149.311 M | 146.168 M | |
| Property Plant Equipment | 34.049 M | 35.529 M | 35.506 M | 36.084 M | 35.355 M | 35.246 M | 34.411 M | 34.202 M | |
| Other Assets | 40.729 M | 38.517 M | 35.511 M | 34.154 M | 33.414 M | 31.244 M | 30.651 M | 29.146 M | |
| Intangible Assets | 43.855 M | 43.051 M | 45.637 M | 43.529 M | 46.455 M | 45.701 M | 43.330 M | 41.896 M | |
| Goodwill | 37.523 M | 37.523 M | 39.615 M | 39.655 M | 40.208 M | 40.336 M | 40.336 M | 40.336 M | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 544.511 M | 542.991 M | 528.217 M | 514.820 M | 501.180 M | 466.826 M | 452.406 M | 466.777 M | |
| Total liabilities | 107.832 M | 112.080 M | 108.196 M | 109.607 M | 107.046 M | 205.498 M | 196.181 M | 202.108 M | |
| Total current liabilities | 70.288 M | 75.975 M | 71.828 M | 74.496 M | 72.674 M | 78.072 M | 70.211 M | 78.331 M | |
| Accounts Payable | 10.625 M | 9.942 M | 12.861 M | 9.880 M | 8.972 M | 12.872 M | 9.976 M | 5.874 M | |
| Other liabilities | 2.823 M | 2.699 M | 4.362 M | 4.471 M | 4.980 M | 99.012 M | 99.034 M | 98.341 M | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 34.708 M | 33.406 M | 32.006 M | 30.589 M | 29.252 M | 28.278 M | 26.893 M | 25.386 M | |
| Other liabilities | 2.823 M | 2.699 M | 4.362 M | 4.471 M | 4.980 M | 99.012 M | 99.034 M | 98.341 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 436.679 M | 430.911 M | 420.021 M | 405.213 M | 394.134 M | 261.328 M | 256.225 M | 264.669 M | |
| Common stock | 53.489 M | 53.532 M | 53.643 M | 53.846 M | 54.179 M | 53.391 M | 51.692 M | 52.196 M | |
| Retained earnings | -441.473 M | -460.444 M | -484.883 M | -509.903 M | -534.202 M | -678.269 M | -695.450 M | -696.844 M |